GLP-1-based therapies, such as GLP-1 receptor agonists, glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors, improve glucose control through various mechanisms including increased insulin secretion, slower gastric emptying, and reduced postprandial glucagon and food intake
Furthermore, lymphovascular invasion is a critical step in tumor dissemination and a strong adverse prognostic factor for breast cancer survival [26]
however, the long reaction time (up to 12 h), low quantum yields (QYs) (about 6%) and complicated protocols are some of the existing limitations
Antithrombin and heparin bind to these factors and disable coagulation
This helps to curb appetite and decrease the amount of food ingested, which is also an action of GLP-1
Some occur naturally in the body and have particular functions,for example the hormone insulin which helps regulate blood sugar levels
